In Vitro and in Vivo Activities of Sch 39304, Fluconazole, and Amphotericin B Against Histoplasma Capsulatum

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1990 Apr 1

PMID 2344160

Citations 9

Authors

G S Kobayashi

S J Travis

M G Rinaldi

G Medoff

Affiliations

Soon will be listed here.

Abstract

The antifungal activities of amphotericin B and two triazoles, Sch 39304 and fluconazole, were tested against Histoplasma capsulatum. In this study Sch 39304 compared favorably with amphotericin B in treating histoplasmosis in normal and leukopenic mice, whereas fluconazole was much less active. The differences in the efficacies of the triazoles appeared to be due to differences in their pharmacokinetics and the dosage schedule that was used. For amphotericin B there was a good correlation between in vitro and in vivo efficacy, but this was not true of the triazole derivatives. These results further demonstrate that, with the methods used in this study, in vitro susceptibility testing of triazoles may not be predictive of in vivo activity against isolates of H. capsulatum.

Citing Articles

In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India.

Kathuria S, Singh P, Meis J, Chowdhary A Antimicrob Agents Chemother. 2014; 58(9):5613-6.

PMID: 24982084 PMC: 4135809. DOI: 10.1128/AAC.02973-14.

In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms.

Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M Antimicrob Agents Chemother. 2003; 47(4):1376-81.

PMID: 12654673 PMC: 152532. DOI: 10.1128/AAC.47.4.1376-1381.2003.

Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.

Connolly P, Wheat L, Schnizlein-Bick C, Durkin M, Kohler S, Smedema M Antimicrob Agents Chemother. 2000; 44(10):2604-8.

PMID: 10991831 PMC: 90122. DOI: 10.1128/AAC.44.10.2604-2608.2000.

Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Sorensen K, Clemons K, Stevens D Mycopathologia. 2000; 146(2):53-65.

PMID: 10822504 DOI: 10.1023/a:1007081707287.

Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

Connolly P, Wheat J, Schnizlein-Bick C, Durkin M, Kohler S, Smedema M Antimicrob Agents Chemother. 1999; 43(2):322-8.

PMID: 9925526 PMC: 89071. DOI: 10.1128/AAC.43.2.322.

References

Savani D, Perfect J, Cobo L, Durack D . Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother. 1987; 31(1):6-10. PMC: 174641. DOI: 10.1128/AAC.31.1.6. View

DuPont B, Drouhet E . Cryptococcal meningitis and fluconazole. Ann Intern Med. 1987; 106(5):778. DOI: 10.7326/0003-4819-106-5-778_2. View

Troke P, Andrews R, Marriott M, Richardson K . Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. J Antimicrob Chemother. 1987; 19(5):663-70. DOI: 10.1093/jac/19.5.663. View

Galgiani J . Antifungal susceptibility tests. Antimicrob Agents Chemother. 1987; 31(12):1867-70. PMC: 175816. DOI: 10.1128/AAC.31.12.1867. View

Kobayashi G, Travis S, Medoff G . Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice. Antimicrob Agents Chemother. 1987; 31(12):2005-6. PMC: 175844. DOI: 10.1128/AAC.31.12.2005. View

Saag M, Dismukes W . Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother. 1988; 32(1):1-8. PMC: 172087. DOI: 10.1128/AAC.32.1.1. View

Hughes C, Bennett R, Tuna I, Beggs W . Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. Antimicrob Agents Chemother. 1988; 32(2):209-12. PMC: 172136. DOI: 10.1128/AAC.32.2.209. View

Cryz Jr S, Furer E, Germanier R . Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect Immun. 1983; 39(3):1067-71. PMC: 348064. DOI: 10.1128/iai.39.3.1067-1071.1983. View

Kobayashi G, Little J, Medoff G . In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester. Antimicrob Agents Chemother. 1985; 27(3):302-5. PMC: 176265. DOI: 10.1128/AAC.27.3.302. View

10.

Richardson K, BRAMMER K, Marriott M, Troke P . Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob Agents Chemother. 1985; 27(5):832-5. PMC: 180161. DOI: 10.1128/AAC.27.5.832. View

11.

Perfect J, Durack D . Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother. 1985; 16(1):81-6. DOI: 10.1093/jac/16.1.81. View

12.

Wheat L . Systemic fungal infections: diagnosis and treatment. I. Histoplasmosis. Infect Dis Clin North Am. 1988; 2(4):841-59. View

13.

Fromtling R . Overview of medically important antifungal azole derivatives. Clin Microbiol Rev. 1988; 1(2):187-217. PMC: 358042. DOI: 10.1128/CMR.1.2.187. View

14.

Harris S, Wallace J, Foulds G, Rinaldi M . Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection. Antimicrob Agents Chemother. 1989; 33(5):714-6. PMC: 172520. DOI: 10.1128/AAC.33.5.714. View

15.

Spitzer E, Travis S, Kobayashi G . Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species. Eur J Clin Microbiol Infect Dis. 1988; 7(1):80-1. DOI: 10.1007/BF01962183. View

16.

Shadomy S, White S, Yu H, Dismukes W . Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole. J Infect Dis. 1985; 152(6):1249-56. DOI: 10.1093/infdis/152.6.1249. View

17.

Troke P, Andrews R, BRAMMER K, Marriott M, Richardson K . Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice. Antimicrob Agents Chemother. 1985; 28(6):815-8. PMC: 180335. DOI: 10.1128/AAC.28.6.815. View

18.

Perfect J, Savani D, Durack D . Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob Agents Chemother. 1986; 29(4):579-83. PMC: 180445. DOI: 10.1128/AAC.29.4.579. View

19.

Kobayashi G, Travis S, Medoff G . Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum. Antimicrob Agents Chemother. 1986; 29(4):660-2. PMC: 180462. DOI: 10.1128/AAC.29.4.660. View

20.

Graybill J, Sun S, Ahrens J . Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858). J Med Vet Mycol. 1986; 24(2):113-9. DOI: 10.1080/02681218680000171. View